NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types

NeoGenomics to Participate in Upcoming Investor Conferences

  • NeoLINK Login
  • Investors
  • Contact Us
Search
LogoNeoLINK Login
Menu
  • Home
  • Providers
    Providers
    • Oncology solutions
      • RaDaR ST MRD
      • PanTracer portfolio
      • Lung cancer
      • Breast cancer
      • Colorectal cancer
      • Gastric cancer
      • Gynecologic cancer
      • Hematologic cancers
    • Pathology solutions
      • Test search
      • Lab services
    • Client support & resources
      • EHR Integrations
      • Certifications & licenses
      • Test requisition forms
      • Pathline clients
  • Partners
    Partners
    • Biopharma services
    • RaDaR ST for Pharma Partners
    • Oncology data solutions
    • Regulatory support
  • Patients
  • About NeoGenomics
    About NeoGenomics
    • Who we are
    • Scientific contributions
    • Oncology view
    • Careers
    • Privacy
    • Contact us
  • Billing
    Billing
    • For clinicians
    • For patients
    • Financial assistance
    • Pay your bill online
  • Test Search
  • Investors
Test Search
Skip to main content Skip to section navigation Skip to footer
NeoGenomics, Inc. IR Overview
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report

Press Releases

Investors News & Events Press Releases
Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Literature
  • Email Alerts
Jul 9, 2019 7:00 am EDT
NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida
Jul 1, 2019 4:01 pm EDT
NeoGenomics Schedules its Second Quarter Earnings Release for July 30, 2019
Jun 27, 2019 4:01 pm EDT
NeoGenomics Announces New $250 Million Credit Agreement
May 30, 2019 4:05 pm EDT
NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference
May 28, 2019 6:00 am EDT
NeoGenomics and QIAGEN Collaborate to Offer Companion Diagnostic Test for HR+/HER2 - Advanced Breast Cancer Patients to Detect a PIK3CA Mutation
May 23, 2019 4:30 pm EDT
NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference
May 21, 2019 8:10 pm EDT
NeoGenomics Announces Pricing on Public Offering of Common Stock
May 20, 2019 4:12 pm EDT
NeoGenomics Announces Proposed Public Offering of Common Stock
Apr 30, 2019 7:00 am EDT
NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter
Apr 3, 2019 4:35 pm EDT
NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • …
  • Page 32
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • rss_feedRSS News Feed
  • account_treeSitemap
©2026 NeoGenomics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences